Angelini Pharma is the pharmaceutical division of Angelini
Group. The Group started almost 100 years ago as a small pharmaceutical laboratory, and over the
years has grown into a leading international group in healthcare, present in
Pharmaceuticals and Mass-Market.
Angelini Pharma is a leader in healthcare, with particular
strength and expertise in the fields of mental health, pain and inflammation and
paediatrics. It aims to help patients, physicians and caregivers in the fight against
diseases. The company is also a leading player in the Consumer Health segment,
with highly successful OTC brands in Italy and abroad.
Angelini products are marketed in about 70 countries. The
company operates directly in 15 countries employing about 3,000 people, and
commercializes its products in more than 50 countries through strategic alliances with leading
international pharmaceutical groups.
As part of its internationalisation strategy, Angelini Pharma has
also concentrated on development in countries with high growth potential.
Angelini Pharma reported a turnover of almost €900 million
in 2018, about half accpunted for by exports.
Angelini Pharma is an integrated pharmaceutical company, with
an extensive R&D operation that has developed important molecules such as trazodone
Current research focuses on pain and inflammation, diseases and
disorders of the nervous system with a particular commitment to the
research of new treatments for the paediatric population.
The research embraces public-private partnerships with
recognised academic institutions and
centres of global importance. The Scientific Network and Partnerships both have an important
role in creating
Angelini's “world class” production plants, all based in
Italy, use cutting-edge technologies and have full certification for quality
standards and respect for the environment. Extensive use is made of renewable energy sources and
sustainability in general.
In Italy, the Ancona plant produces finished pharmaceutical
products and the industrial factory in Aprilia cretes pharmaceutical raw materials, while
disinfectants and sanitising products under the Amuchina brand are produced in